Published in Hepatitis Weekly, October 16th, 2000
As a result, physicians had little to offer the patients in terms of treatment options, and instead focused on providing therapy that would relieve the patients' suffering.
The results were from a retrospective study of patients who presented with hepatocellular carcinoma to the University of Vienna, Austria, hospital. The number of patients being treated for hepatocellular carcinoma (HCC) at this hospital has been increasing for several years.
Researchers analyzed several characteristics in the 245 hepatocellular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.